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Abstract
Accurate measurements of the abundances, synthesis rates and degradation rates of cellular
proteins are critical for understanding how cells and organisms respond to changes in their
environments. Over the past two decades, there has been increasing interest in the use of mass
spectrometry for proteomic analysis. In many systems, however, protein diversity as well as cell
and tissue heterogeneity limit the usefulness of mass spectrometry-based proteomics. As a result,
researchers have had difficulty in systematically identifying proteins expressed within specified
time intervals, or low abundance proteins expressed in specific tissues or in a few cells in complex
microbial systems. In this review, we present recently-developed tools and strategies that probe
these two subsets of the proteome: proteins synthesized during well-defined time intervals –
temporally resolved proteomics – and proteins expressed in predetermined cell types, cells or
cellular compartments – spatially resolved proteomics – with a focus on chemical and biological
mass spectrometry-based methodologies.
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Introduction
Messenger RNA (mRNA) profiling at the systems level (transcriptomics) with microarray or
deep-sequencing technologies offers a high-throughput route to the analysis of gene
expression.26,91 However, transcriptomic methods are blind to post-transcriptional
phenomena such as translational regulation, protein modification, protein-protein
interactions or protein interactions with other molecular components. Furthermore, because
mRNA abundance correlates poorly with protein abundance,15,82,89 reliable quantitative
information about changes in protein abundance cannot be derived from microarray
analysis.
Recent advances in genomic sequencing and high-resolution mass spectrometry have
enabled rapid progress in the study of proteins and their abundances, modifications,
interactions and functions.1,93 Sample analysis workflows that employ high-resolution liquid
chromatography-tandem mass spectrometry (LC-MS/MS) use site-specific endopeptidases
(e.g., trypsin or Lys-C) to convert mixtures of proteins into peptides.60 Microscale or
nanoscale high-performance liquid chromatography (HPLC)54 and/or ion exchange (IEX)
chromatography20 separates the peptides and injects them into the mass spectrometer. After
an initial ion scan (MS1), peptide ions fragment in the mass spectrometer and yield
secondary “MS/MS” (MS2) spectra. Peptide search engines like Mascot or Andromeda
match the MS/MS spectra with theoretical MS/MS spectra and recover the corresponding
peptide sequences from a database.12,73 Finally, proteins are identified using two or more
unique peptides. Mass spectrometry-based proteomic methods have been applied to a wide
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range of problems including deciphering the protein composition of organelles,9
systematically mapping protein-protein interactions,63 and large-scale decoding of post-
translational events in response to stimuli.24
As of this writing, no eukaryotic proteome has been mapped with 100% coverage.63–64 The
dynamic range of protein expression can span many orders of magnitude (e.g., up to 12
orders of magnitude in serum11). The resulting variations in protein abundance challenge the
dynamic range and sequencing speed of contemporary mass spectrometers. Sequence
coverage becomes increasingly important in the analysis of higher eukaryotes where
proteins exhibit high levels of sequence homology due to evolution of protein families,
alternative splicing and differential processing.3,8,69 Furthermore, while genome-wide
transcriptome analyses are now routinely performed on small samples of RNA, even from
single cells,68 low abundance proteins cannot be amplified to improve identification rates.
To expand the dynamic range of identified proteins, researchers have focused on
information-rich subsets of the proteome, such as the glycoproteome,35 phosphoproteome85
and ubiquitome.86 In this review, we highlight recent work that leverages mass spectrometry
and chemical biology to examine two additional subsets of the proteome: proteins
synthesized during predetermined time intervals – temporally resolved proteomics – and
proteins expressed in specific cell types, cells or cellular compartments – spatially resolved
proteomics.
Temporally Resolved Proteomic Analysis
Stable-Isotope Labeling with Amino Acids in Cell Culture (SILAC)
Interest in quantitative modeling and analysis of biological processes has motivated the
development of tools for quantitative mass spectrometry-based proteomics such as “label-
free” and isotopically labeled protein profiling.4–5 Comparison of protein abundances in
different samples is most accurately accomplished by using stable isotopes.4,5,78 Stable-
isotope labeling of peptides relies on either chemical methods that attach isotopically labeled
linkers to peptides (e.g., ICAT27 or iTRAQ92) or metabolic methods that incorporate
isotopically labeled amino acids into peptides (e.g., 15N-labeling40 or SILAC61).
Stable-isotope labeling by amino acids in cell culture (SILAC, Figure 1, Top Left)
introduces the label at the amino acid level and overcomes complex isotopic clusters found
in alternative metabolic methods like 15N-labeling. Distinct isotopologs of the labeled amino
acids – typically “light” arginine (12C614N41H1416O2) and “light” lysine
(12C614N21H1416O2) in one sample, and “heavy” arginine (13C615N41H1416O2) and “heavy”
lysine (13C615N21H1416O2) in the other – are added to the samples of interest. After several
generations of growth, all cellular proteins have uniformly incorporated the labeled amino
acids. Cells are lysed and subjected to proteolysis, and the resulting peptide pools are mixed.
In theory, both the “heavy” and “light” forms of each peptide should behave identically with
respect to processing and LC-MS/MS analysis. However, the origin of each peptide can be
determined from the mass of its isotope label, and the relative signal intensities of the
“heavy” and “light” peptides indicate the relative abundances of the corresponding proteins
in the two samples. Its simplicity and accuracy have made SILAC an increasingly popular
method, both for cell culture-based quantitative proteomics,50 and for whole organism
quantitative proteomics.15,21,41,43,80
Repurposing SILAC for Temporally Resolved Proteomic Analysis
Because “old” and “new” copies of cellular proteins are chemically indistinguishable,
selective analysis of the subset of the proteome that is expressed within a specified time
interval is challenging. A classic method for quantifying specific protein turnover rates
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involves pulse labeling cells with a radiolabeled amino acid (typically 35S-methionine or
cysteine).44,55 Only those proteins synthesized during the pulse incorporate the radioactive
element, and their fates can be monitored by standard radioisotope methods. Analogous
pulse labeling with stable isotopes can also determine protein turnover or transport (Figure
1, Top Middle).42,53,65
Pulse labeling with amino acids and nucleosides can be combined to yield an unbiased and
comprehensive picture of protein and mRNA dynamics. To determine if the cellular
abundance of proteins is predominantly controlled at the level of transcription or translation,
Schwanhäausser et al. pulse labeled mammalian cells with the nucleoside analog 4-
thiouridine (Figure 2) and heavy arginine and lysine to quantify absolute mRNA and protein
abundances, half-lives and transcription and translation rates for more than 5000 genes in
mouse fibroblast cells.76 The thio-substituted nucleoside 4-thiouridine is not a natural
component of nucleic acids but is incorporated into RNA biosynthetically; only newly
synthesized RNAs are thio-labeled and can be tagged and purified using commercially
available reagents.22,67 Although mRNA and protein levels correlated better than in
previous studies,15,16,49,82,89,90 their half-lives showed no overall correlation. Nevertheless,
the authors note that genes with similar combinations of mRNA and protein half-lives share
common functions, suggesting that half-lives evolved under similar constraints. For
example, many genes involved in constitutive processes like translation, respiration and
central metabolism have stable mRNAs and proteins, consistent with the requirement for
conservation of resources. On the other hand, genes involved in transcription regulation,
signaling, chromatin modification and cell cycle-specific processes have unstable mRNAs
and proteins, consistent with the requirement for rapid regulation. Correlation of protein
abundance with mRNA levels and with translation rates showed that protein copy numbers
are determined primarily at the level of translation.
Pulsed Stable-Isotope Labeling with Amino Acids in Cell Culture (pSILAC)
Unlike pulse labeling with a single label to determine protein turnover or transport in the
same sample, pulsed stable-isotope labeling with amino acids in cell culture (pSILAC,
Figure 1, Top Right) quantifies differences in protein synthesis between different samples
integrated over the measurement time after the pulse. In pSILAC, cells in two different
samples previously cultured in light media are transferred to two different pulse media: one
containing heavy amino acids (typically arginine-10: 13C615N41H1416O2 and
lysine-8: 13C615N21H1416O2) and the other containing “medium-heavy” amino acids (e.g.,
arginine-6: 13C614N41H102H416O2 and lysine-4: 12C614N21H102H416O2).75,77 During
labeling, only newly synthesized proteins incorporate either the heavy or the medium-heavy
amino acids. Peptides derived from heavy or medium-heavy proteins are distinguishable
during the initial ion scan from pre-existing, light proteins on the basis of the mass
difference introduced by the isotope label. Intensity ratios for heavy and medium-heavy
peptides directly indicate the relative abundances of the corresponding newly synthesized
proteins in the samples of interest. Light pre-existing peptides are identified but ignored
during quantification.
Selbach and coworkers introduced pSILAC in 2008 as a method to measure changes in
protein translation involved in cellular iron homeostasis.75 Since then, researchers have used
pSILAC to assess protein dynamics associated with microRNA overexpression,34,62,77
monocyte-macrophage differentiation,37 hyperglycemia-induced stress95 and mammalian
target of rapamycin inhibition.33 Selbach et al. utilized pSILAC to measure changes in the
synthesis of several thousand proteins in HeLa cells in response to either microRNA
transfection or endogenous microRNA knockdown.77 HeLa cells cultivated in light media
were first transfected with miR-1, miR-155, miR-16, miR-30a, or let-7b, or mock
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transfected. Eight hours later, cells were transferred to media containing either medium-
heavy or heavy amino acids for 24 hours. Unexpectedly, pSILAC in this study and
subsequent studies revealed that overexpression of a single microRNA can lead to
repression of hundreds of proteins; however the repressive effect was relatively small and
rarely exceeded fourfold.34,62 These results cast microRNAs as general orchestrators that
tune cellular physiology and metabolism in subtle ways in response to specific cues.
Bio-Orthogonal Non-Canonical Amino Acid Tagging (BONCAT)
Under some circumstances (e.g., for short labeling times), the dynamic range and
complexity of the proteome can preclude reliable identification and analysis of low-
abundance isotope-labeled proteins in the presence of more abundant pre-existing proteins.
Moreover, the use of multiple labels increases the number of distinct peptide forms and the
computational complexity associated with protein identification. These limitations can be
addressed by selective enrichment and identification of newly synthesized proteins.
In 2006, Dieterich et al. introduced the bio-orthogonal non-canonical amino acid tagging
(BONCAT, Figure 1, Bottom Left) strategy to enable selective enrichment and
identification of newly synthesized proteins in cells and tissues.17 This strategy relies on
bio-orthogonal functional groups – functional groups that react rapidly and selectively with
each other but remain inert to the functional groups normally found in biological systems.66
An exemplary bio-orthogonal group, the azide is small, kinetically stable and absent from
living systems, yet can be modified easily and selectively through the Staudinger ligation
with triarylphosphine reagents,74 the copper(I)-catalyzed “click” cycloaddition with terminal
alkynes72,87 or the strain-promoted “click” cycloaddition with strained cyclooctynes.2
BONCAT employs a two-stage procedure. First, pulse labeling of cells or tissues with the
azide-bearing methionine (Met, Figure 2) analog azidohomoalanine (Aha, Figure 2) or the
alkyne-bearing methionine analog homopropargylglycine (Hpg, Figure 2) enables metabolic
incorporation of either azide or alkyne functional groups into the proteome. In bacterial and
mammalian systems, wild-type methionyl-tRNA synthetases (MetRSs) are capable of
appending the non-canonical amino acid Aha (or Hpg) to cognate transfer RNAs
(tRNAMet).17,36 Aha (or Hpg) is thereby incorporated into proteins made during the Aha (or
Hpg) pulse. Second, a bio-orthogonal ligation with the complementary reactive group
conjugated to a probe enables detection of Aha- or Hpg-tagged proteins. Treatment of azide-
tagged proteins with alkyne-functionalized fluorescent dyes permits visualization of newly
synthesized proteins.6,7,18 Alternatively, treatment of azide-tagged proteins with alkyne-
functionalized affinity reagents allows selective enrichment of proteins made during the Aha
pulse. Enriched proteins can then be identified by LC-MS/MS.56,81
BONCAT has been used in mammalian cells,17 in both unicellular38–39 and multicellular
organisms,29 and even adapted to measure genome-wide nucleosome turnover dynamics in
Drosophila S2 cells.14 Here, we highlight a few recent examples with an emphasis on
proteomic discovery. Zhang et al. reported a tandem labeling (Aha and alkyne-
functionalized palmitic acid) and detection method to monitor the dynamic acylation of Lck,
an N-myristoylated and S-palmitoylated non-receptor tyrosine kinase required for T-cell
activation.96 Liu et al. expanded on this concept by enriching proteins made in Jurkat cells
during a specified time interval, then progressively monitoring their post-translational
modifications over time by quantitative in-gel fluorescence scanning with Aha/Hpg and
eight additional azide- and alkyne-functionalized post-translational modification probes.47
The up-regulation of myristoylated protein kinase A was found to be intimately linked to
butyric acid-induced apoptosis.
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Because local protein synthesis is critical for long-term functional synaptic changes,
BONCAT is an attractive tool for neurobiological studies. Tcherkezian et al. examined the
colocalization of DCC (Deleted in Colorectal Cancer) transmembrane receptors with newly
synthesized proteins in cultured commissural axon growth cones with Aha-labeling.84
Hodas et al. used BONCAT to identify proteins translated in intact hippocampal neuropil
sections upon treatment with the selective D1/D5 dopamine receptor agonist SKF81297.30
Yoon et al. developed DIGE-NCAT – a combination of 2D difference gel electrophoresis
(2D-DIGE) and BONCAT – to examine changes in the proteome of Xenopus retinal
ganglion cell (RGC) axons in response to stimulation with Engrailed-1.94 Engrailed-1
belongs to a family of transcription factors previously shown to cause rapid translation-
dependent guidance responses in RGC axons.10 The authors first severed distal portions of
the axon bundles from Xenopus eyes and stimulated them with Engrailed-1 for 1 hour along
with the addition of Aha. Next, Aha-tagged axonally synthesized proteins were treated with
an alkynyl dye and resolved on 2D-DIGE. Compared to control gels, spots with the greatest
difference in fluorescence were analyzed by matrix-assisted laser desorption/ionization-
time-of-flight mass spectrometry (MALDI-TOF MS). Surprisingly, this strategy revealed
that the intermediate filament protein lamin B2 (LB2) – normally associated with the nuclear
membrane – is axonally synthesized in response to stimulation. Coupled with the finding of
LB2’s association with mitochondria, these results suggest that LB2-promotion of
mitochondrial function is needed for axon maintenance.
Quantitative Non-Canonical Amino Acid Tagging (QuaNCAT)
How can we quantitatively study proteomic changes during short time intervals (e.g., in
response to a stimulus) without the complications that arise from the abundance of pre-
existing proteins? As labeling times decrease, co-eluting pre-existing peptides increasingly
obscure low abundance pSILAC-labeled peptides during the first mass spectrometry scan.
To overcome this limitation, pSILAC and BONCAT have been combined in an approach
designated Quantitative Non-Canonical Amino Acid Tagging (QuaNCAT, Figure 1, Bottom
Right). In a QuaNCAT experiment, two parallel populations of cells in light media are
transferred for a limited time to either medium-heavy or heavy media that also contain
Aha.19,31 During the labeling period, newly synthesized proteins incorporate either the
heavy or medium-heavy amino acid as well as Aha. Through BONCAT enrichment of the
combined protein pools, pre-existing light peptides are greatly reduced in abundance. As in
pSILAC, ratios of intensities of heavy and medium-heavy peptides directly indicate the
relative abundances of newly synthesized proteins in the two samples.
To determine the benefit of selectively enriching and quantifying secreted proteins,
Eichelbaum et al. labeled two human cell lines (PC3 and WPMY-1) with Aha and
isotopologs of arginine and lysine for 24 hours.19 With enrichment via on-bead azide-alkyne
cycloaddition and trypsin digestion, 684 secreted proteins were quantified with high
correlation (R = 0.96) between biological duplicates. Without enrichment, only 22 proteins
were quantified with low correlation (R = 0.02). The authors identified as many as 500
proteins, even at short labeling times (2 hours), including several known lipopolysaccharide
(LPS) effector proteins as well as many other previously unassociated proteins during LPS
stimulation of mouse macrophages. Howden et al. tested QuaNCAT by examining changes
in expression of more than 600 proteins enriched from freshly isolated human CD4-positive
T cells stimulated by activation with phorbol 12-myristate 13-acetate and ionomycin during
2 and 4 hour pulses.31 Many transcription factors and transcriptional regulators, cytokines,
activation surface markers, protein chaperones and proteins involved in cytoskeleton
dynamics and vesicle transport, were among the proteins found to be substantially increased
in expression following stimulation. While less than 1% of the proteome was labeled in a 2
hour pulse, the post-enrichment protein pool consisted of 10–20% heavy and medium-heavy
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proteins. The ability to resolve protein abundance changes over very short time spans should
prove useful when studying systems previously thought to be “unquantifiable” by SILAC
such as short-lived progenitor or primary cells.32
O-Propargyl-Puromycin Labeling
Salic and coworkers have developed an alternative approach to the selective labeling of
newly synthesized proteins, in which a puromycin analog (O-propargyl-puromycin, Figure
3, Top) bearing a terminal alkyne is used to label nascent polypeptide chains.46 Puromycin
mimics aminoacyl-tRNAs and terminates translational elongation after entering the acceptor
site of the ribosome. Salic and coworkers showed that O-propargyl-puromycin not only
terminates nascent polypeptide chains but also appends an alkyne label at the C-terminus.
Liu and co-workers injected mice intraperitoneally with O-propargyl-puromycin and
harvested tissues 1 hour later. Tissues from these mice displayed specific patterns of O-
propargyl-puromycin incorporation into nascent proteins. For example, in the small
intestine, the most intense labeling occurred in cells in the crypts and at the base of intestinal
villi, consistent with the high proliferative and secretory activity of these cells (Figure 3,
Bottom).
Spatially Resolved Proteomic Analysis
Coupling Flow Cytometry and Mass Spectrometry
Proteomic analysis of rare cells in heterogeneous environments presents important, difficult
challenges. Combining flow cytometry with quantitative proteomics provides a solution in
some systems of this kind. For example, Rechavi et al. combined quantitative proteomics
and high-purity cell sorting to discover proteins transferred from human B cells to natural
killer cells.70 These authors developed a strategy called “trans-SILAC,” in which one cell
type – capable of transferring proteins – is labeled with heavy arginine and lysine and the
other cell type – the recipient of transferred proteins – remains unlabeled. To initiate
contact- and actin cytoskeleton-dependent protein transfer, the heavy “donor” B cells and
freshly isolated light “recipient” natural killer cells were co-incubated for 1.5 hours.
Fluorescence-activated cell sorting separated recipient cells from donor cells before the
proteomic workflow, and transferred proteins in the recipient cells were identified by their
mass shifts. Analysis of the transferred proteins revealed significant enrichment for the
annotation term “MHC class II protein complex”, as expected.
Cell-Selective BONCAT
Although some cell types can be isolated for proteomic analysis through cell sorting or
laser-capture techniques, others cannot. Subsets of neurons or glia in the central nervous
system, for example, are difficult to isolate by dissection or dissociation methods. Or
perhaps one would like to analyze proteomic responses of pathogenic bacteria hiding inside
host cells, or of specific cells in multicellular animals, without interference from proteins
derived from the host or from all of the other cells in the animal. Can we perform these
kinds of tasks without prior separation of the cells of interest?
Promising solutions to analogous problems in genomics and transcriptomics rely on spatially
restricted enzymatic labeling. In 2010, Henikoff and coworkers developed INTACT
(isolation of nuclei tagged in specific cell types) – a method that allows affinity-based
isolation of nuclei from individual cell types in a tissue.13 In INTACT, the spatial restriction
of the Escherichia coli biotin ligase BirA and a nuclear targeting fusion protein results in
biotin-labeled nuclei in the cell type of choice. First described in Arabidopsis, INTACT has
been extended to profile gene expression and histone modifications in adult Caenorhabditis
muscle79 and Kenyon cells and octopaminergic neurons in the adult Drosophila brain.28
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For RNA, Miller et al. developed TU-tagging, a method that allows affinity-based isolation
of RNA from individual cell types of a tissue.52 In TU-tagging, the spatial restriction of the
Toxoplasma gondii nucleotide salvage enzyme uracil phosphoribosyltransferase enables
RNA in the cell type of choice to be labeled with 4-thiouracil (Figure 2). Unlike 4-
thiouridine, 4-thiouracil is not recognized by the endogenous biosynthetic machinery.
Recently, Gay et al. used TU-tagging to purify transcripts from rare (<5%) cells, such as
Tie2:Cre+ brain endothelia/microglia in mice.23
Analogous strategies have been developed for cell-selective proteomic analysis. Because
endogenous methionyl-tRNA synthetases charge Aha to cognate tRNAs in all cell types,
Aha-based BONCAT is not cell-selective – newly synthesized proteins in all cell types are
labeled. To enable cell-selective proteomic analysis, Tirrell and coworkers engineered a
family of mutant E. coli MetRSs capable of appending the azide-bearing methionine analog
azidonorleucine (Anl, Figure 2) to tRNAMet.45,83 Anl is not a good substrate for any of the
wild-type aminoacyl-tRNA synthetases in bacteria to mammals; it is excluded from proteins
made in wild-type cells but incorporated readily into proteins made in cells that express an
appropriately engineered MetRS. Anl-labeling does not require depletion of methionine if
the mutant MetRS activates Anl faster than methionine.
Ngo et al. first achieved cell type-selectivity by outfitting an E. coli strain with the L13N/
Y260L/H301L mutant form of the E. coli MetRS (NLL-EcMetRS). Proteins made in this
strain could be labeled with Anl in co-culture with murine alveolar macrophages, which
were not labeled (Figure 4).59 Bacterial proteins were effectively separated from murine
proteins by treatment of mixed lysates with alkyne-functionalized biotin reagents and
subsequent affinity chromatography on NeutrAvidin resin.
System-wide identification of bacterial proteins expressed or secreted during infection can
provide new insight into mechanisms of bacterial pathogenesis. Grammel et al. studied
cultures of Raw264.7 murine macrophages infected with S. typhimurium (a Gram-negative
intracellular pathogen) outfitted with the NLL-EcMetRS.25 Cultures were pulse-labeled with
2-aminooctynoic acid (Aoa, Figure 2), an alkyne analog of Anl, for 1 hour. Of the 218
proteins identified, 185 (85 %) were Salmonella proteins and 33 were mouse proteins. Five
of the Salmonella proteins (SodM, SsrB, SseA, PipB2, and PhoP) had been previously
described as virulence factors.
In more recent work, Ngo and co-workers demonstrated that heterologous expression of the
NLL-EcMetRS enables incorporation of Anl into proteins expressed in human (HEK293)
cells, permitting enrichment and visualization of proteins made during various stages of the
cell cycle.58 Interestingly, Anl replaces methionine selectively at N-terminal positions not at
internal sites. Site-selectivity occurs because NLL-EcMetRS catalyzes aminoacylation only
of the mammalian initiator tRNAMet, not the mammalian elongator tRNAMet. Through
judicious selection of regulatory elements, systems of this kind will enable cell-selective or
“cell-state-selective”57 interrogation of protein synthesis in co-cultures of mammalian cells,
in virally transfected tissues or even in living animals.
To expand the set of tools available for cell-selective BONCAT, Truong et al. engineered a
MetRS variant capable of activating propargylglycine (Pra, Figure 2) but not Anl.88 Pra is an
alkynyl amino acid smaller than methionine and is not activated by wild-type aminoacyl-
tRNA synthetases or by NLL-EcMetRS. Using directed evolution, Truong et al isolated a
MetRS variant (designated propargylglycyl-tRNA synthetase; PraRS, L13P/A256G/P257T/
Y260Q/H301F/A331V/Δ548E) capable of near-quantitative replacement of Met by Pra in
proteins. In protein mixtures that have been labeled both with Anl and with Pra, treatment
with cyclooctyne-functionalized probes selectively tags Anl side chains, and subsequent
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treatment with azide-functionalized probes selectively tags Pra side chains. By using one
promoter to drive expression of NLL-EcMetRS in one cell and a different promoter to drive
expression of PraRS in another cell, researchers can perform differential, cell-selective
BONCAT in complex multicellular systems without prior separation.
Restricting expression of mutant methionyl-tRNA synthetases by using promoters active
only in specific cells or tissues should restrict Anl/Aoa labeling to those cells or tissues.
Additional specificity should be possible by exploiting the combinatorial action of multiple
regulators. To this end, Mahdavi et al. bisected the NLL-EcMetRS and found several split
variants capable of charging Anl to tRNAMet.48 Because labeling requires expression of
both the N- and C-terminal fragments of the synthetase, this system allows the investigator
to restrict labeling to cells in which two promoters of interest are active.
Ascorbate Peroxidase (APEX) Labeling
Ting and coworkers have recently used an engineered variant of ascorbate peroxidase
(APEX) to selectively tag proteins that localize to the mitochondrial matrix in living cells.71
The Ting laboratory had previously used APEX to catalyze the H2O2-dependent
polymerization of diaminobenzidine to provide contrast in electron microscopy.51 They
genetically targeted APEX to the mitochondrial matrix of human embryonic kidney (HEK)
cells, initiated labeling by adding biotin-phenol and H2O2, and stopped labeling after 1
minute by cell fixation or lysis (Figure 5). APEX processes biotin-phenol in a hydrogen
peroxide-dependent manner to yield highly reactive products that covalently link biotin to
electron-rich amino acids such as tyrosine, tryptophan, histidine and cysteine. Unlike cell-
selective BONCAT, APEX labeling is not time-selective. Any proteins accessible to the
phenoxyl radical -- including pre-existing proteins made before the biotin-phenol pulse --
are biotinylated in the 1 minute “snapshot”. Enrichment and mass spectrometry of the
biotinylated proteins led to identification of 464 known mitochondrial proteins as well as 31
that were not previously known to localize to mitochondria. Demonstrating APEX-based
proteomics as a viable discovery tool, a random subset of these 31 “mitochondrial orphans”
were verified by fluorescence imaging to have complete or partial mitochondrial
localization.
Conclusion
This review highlights chemical biological strategies that allow researchers to identify,
isolate and quantitatively analyze proteins within defined windows of time and space. Many
of these strategies rely on amino acids with isotopic signatures or functional groups that are
not found in biological systems. Incorporation of these “tags” permits the investigator to
distinguish proteins made in different time intervals or in different cells or organelles. In
combination with these tagging methods, mass spectrometry becomes an even more
powerful tool for addressing complex biological questions.
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Figure 1.
Cells can be metabolically labeled with a combination of Aha and/or stable isotopic variants
of arginine and lysine in 5 workflows: standard SILAC (top left), pulse labeling with heavy
amino acids (top middle), pSILAC (top right), BONCAT (bottom left) and QuaNCAT
(bottom right).
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Figure 2.
Structures discussed in this review: amino acids for stable isotopic labeling (top row),
methionine and analogs that are substrates for wild-type methionyl-tRNA synthetases
(second row), methionine analogs that require the expression of mutant methionyl-tRNA
synthetases for proteomic incorporation (third row), and uridine and uracil as well as their
thio-substituted analogs 4-thiouridine and 4-thiouracil (last row).
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Figure 3.
(Top) Both puromycin and its alkyne-functionalized analog O-propargyl-puromycin
incorporate into nascent polypeptide chains on translating ribosomes, resulting in premature
termination of nascent polypeptide chains. (Bottom) Sectioning of mouse small intestine
showed that OP-Puro labeling occurred primarily in cells in the crypts and the cells at the
base of the villi. (Adapted with permission from Liu et al., Proc. Natl. Acad. Sci. U.S.A.,
109, 413–418, 2012. Copyright 2012 Proceedings of the National Academy of Sciences
USA.)
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Figure 4.
(Top) Cell-selective BONCAT performed in a mixture of cells. Restricting expression of a
mutant synthetase to a certain cell restricts Anl labeling to that cell (highlighted in blue).
Proteins synthesized in cells (highlighted in gray) that do not express the mutant synthetase
are neither labeled nor detected following enrichment. (Bottom) Cell-selective labeling in
mixtures of bacterial and mammalian cells. (a) In Anl-containing mixed cultures of E. coli
and mouse alveolar macrophages, only E. coli cells constitutively expressing the mutant
NLL-EcMetRS were labeled by TAMRA-alkyne. Macrophages were labeled with
Mitotracker Deep Red and displayed low TAMRA-alkyne background emission. (b) In Aha-
containing mixed cultures of E. coli and mouse alveolar macrophages, both wild-type E. coli
cells and macrophages exhibited strong TAMRA-alkyne emission; incorporation of Aha
occurs in both cell types. (c) Mixed cell lysate was subjected to conjugation with alkyne-
functionalized biotin, and labeled proteins were enriched by NeutrAvidin affinity
chromatography. Immunoblotting of unbound flow-through (FT), washes (W1, W3, W5)
and eluent (E) reveals enrichment of the bacterial marker protein GFP. (Adapted with
permission from Ngo et al., Nat. Chem. Biol., 5, 715–717, 2009. Copyright 2009 Nature
Publishing Group.)
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Figure 5.
(Top) Selective labeling of the mitochondrial matrix proteome in living cells requires 1)
genetically targeting APEX to the mitochondrial matrix (mito-APEX), 2) initiating
biotinylation by adding biotin-phenol and H2O2 to the medium, and 3) stopping
biotinylation by cell fixation or lysis. (Middle) In human embryonic kidney cells, only
mitochondria that expressed mito-APEX and were exposed to both biotin-phenol and H2O2
contained biotinylated proteins (stained with NeutrAvidin-Alexa Fluor 647). Both confocal
fluorescence imaging (Middle) and stochastic optical reconstruction microscopy (STORM)
(Bottom) showed that biotinylated proteins (stained with Streptavidin-Cy3/Cy5 for STORM
images) overlapped with mito-APEX only in the mitochondrial matrix. (Adapted with
permission from Rhee et al., Science, 339, 1328–1331, 2013. Copyright 2013 The American
Association for the Advancement of Science.)
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